These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20637998)

  • 41. Neuro-ophthalmic sarcoidosis: the University of Iowa experience.
    Koczman JJ; Rouleau J; Gaunt M; Kardon RH; Wall M; Lee AG
    Semin Ophthalmol; 2008; 23(3):157-68. PubMed ID: 18432542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences].
    Juri J; Stiglmayer N; Kuzman T
    Acta Med Croatica; 2006; 60(2):83-6. PubMed ID: 16848193
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Thyroid orbitopathy and diabetes].
    Cáp J
    Vnitr Lek; 2007 May; 53(5):524-7. PubMed ID: 17642437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recent developments in the medical treatment of thyroid eye disease.
    Krassas GE; Boboridis K
    Orbit; 2006 Jun; 25(2):117-22. PubMed ID: 16754220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis.
    Kvetny J; Puhakka KB; Røhl L
    Acta Ophthalmol Scand; 2006 Jun; 84(3):419-23. PubMed ID: 16704711
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical manifestations of thyroid ophthalmopathy].
    Fernández Hermida RV; Pinar S; Muruzábal N
    An Sist Sanit Navar; 2008; 31 Suppl 3():45-56. PubMed ID: 19169294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
    Zoumalan CI; Cockerham KP; Turbin RE; Volpe NJ; Kazim M; Douglas RS; Feldon SE
    J Neuroophthalmol; 2007 Sep; 27(3):205-14. PubMed ID: 17895822
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Thyroid-associated ophthalmopathy].
    Kloster R; Elverland HH; Pierre-Jerome C; Trumpy JH
    Tidsskr Nor Laegeforen; 1998 Jun; 118(15):2332-4. PubMed ID: 9691800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thyroid ocular myopathy.
    Hodes BL; Shoch DE
    Trans Am Ophthalmol Soc; 1979; 77():80-103. PubMed ID: 583536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility Assessment of Moderate to Severe Thyroid Eye Disease Health States.
    Smith TJ; Cockerham K; Lelli G; Choudhary C; Taylor S; Barretto N; Enstone A; Oliver L; Lynch J; Holt RJ
    JAMA Ophthalmol; 2023 Feb; 141(2):159-166. PubMed ID: 36580313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The ocular surface in thyroid diseases.
    Versura P; Campos EC
    Curr Opin Allergy Clin Immunol; 2010 Oct; 10(5):486-92. PubMed ID: 20724921
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The "Quiet TED"-A Special Subgroup of Thyroid Eye Disease.
    Iñiguez-Ariza NM; Sharma A; Garrity JA; Stan MN
    Ophthalmic Plast Reconstr Surg; 2021 Nov-Dec 01; 37(6):551-555. PubMed ID: 33782324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammatory and Noninflammatory Thyroid Eye Disease: Comparison of Disease Signs, Symptoms, and Quality of Life in Patients in the United States.
    Wang Y; Padnick-Silver L; Francis-Sedlak M; Holt RJ; Foley C; Douglas RS
    Endocr Pract; 2022 Sep; 28(9):842-846. PubMed ID: 35714862
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical update: treatment of hyperthyroidism in Graves' ophthalmopathy.
    Azzam I; Tordjman K
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():193-7. PubMed ID: 20467362
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Idiopathic orbital hemorrhage related to the inferior rectus muscle: a rare cause for acute-onset diplopia and unilateral proptosis.
    Ben Simon GJ; McNab AA
    Ophthalmology; 2005 Oct; 112(10):1838-43. PubMed ID: 16095703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The application of temperature measurement of the eyes by digital infrared thermal imaging as a prognostic factor of methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Shih SR; Li HY; Hsiao YL; Chang TC
    Acta Ophthalmol; 2010 Aug; 88(5):e154-9. PubMed ID: 20553230
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on Graves disease: advances in treatment of mild, moderate and severe thyroid eye disease.
    Strianese D
    Curr Opin Ophthalmol; 2017 Sep; 28(5):505-513. PubMed ID: 28700384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Update on the clinical assessment and management of thyroid eye disease.
    Roos JCP; Murthy R
    Curr Opin Ophthalmol; 2019 Sep; 30(5):401-406. PubMed ID: 31313753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thyroid eye disease: therapy in the active phase: a comment.
    Stiebel-Kalish H; Robenshtok E
    J Neuroophthalmol; 2014 Dec; 34(4):425-6. PubMed ID: 25365144
    [No Abstract]   [Full Text] [Related]  

  • 60. Thyroid eye disease: therapy in the active phase: a comment: reply.
    Bhatti MT; Dutton JJ
    J Neuroophthalmol; 2014 Dec; 34(4):426-7. PubMed ID: 25365145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.